-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Cytek Biosciences, Inc. quarterly/annual Deferred Income Tax Expense (Benefit) history and change rate from 2020 to Q1 2025.
- Cytek Biosciences, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending 31 Mar 2025 was -$336K.
- Cytek Biosciences, Inc. annual Deferred Income Tax Expense (Benefit) for 2024 was -$2.89M.
- Cytek Biosciences, Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was $0.000.
- Cytek Biosciences, Inc. annual Deferred Income Tax Expense (Benefit) for 2022 was $0.000.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Change (%)